Pharmacokinetic Studies of 5‐Fluorouracil after Oral and Intravenous Administration in Man
- 1 May 1980
- journal article
- research article
- Published by Wiley in Acta Pharmacologica et Toxicologica
- Vol. 46 (5) , 329-336
- https://doi.org/10.1111/j.1600-0773.1980.tb02463.x
Abstract
The pharmacokinetic conditions for oral administration of 5-fluorouracil (5-FU) were investigated in 16 patients with malignant liver tumours. The concentration of 5-FU in portal and systemic blood was determined by a microbiologic method every 10 min. during 2 hours after oral or intravenous administration of a standard dose of 250 mg 5-FU (∼ 4 mg/kg b.wt.) or 15 mg 5-FU/kg b.wt. The drug was rapidly absorbed after oral administration with peak values within 10–30 min. 25% of the lower and 40% of the higher oral dose reached the systemic circulation. The reduction of systemic bio-availability was partly accomplished by a loss in the gastrointestinal tract and partly by extraction by the liver. The hepatic extraction ratio was calculated to 0.56 and 0.26 after the lower and the higher dose respectively indicating a saturable process. The availability of 5-FU was significantly higher in portal blood than in systemic blood after oral administration. The opposite conditions were found after intravenous administration. Thus, oral administration of 5-FU to patients with malignant liver tumours seems rational.Keywords
This publication has 17 references indexed in Scilit:
- Kinetics and Mechanisms of Drug Action on Microorganisms XXIII: Microbial Kinetic Assay for Fluorouracil in Biological Fluids and Its Application to Human PharmacokineticsJournal of Pharmaceutical Sciences, 1977
- Pharmacokinetics of 5-FluorouracilClinical Pharmacokinetics, 1977
- Pharmacokinetics of the fluoropyrimidines: implications for their clinical useCancer Treatment Reviews, 1976
- Inactivation of 5-Fluorouracil by the Liver during Continuous Regional and Systemic Infusion in PigsEuropean Surgical Research, 1976
- Fluorinated Pyrimidines and Their NucleosidesPublished by Springer Nature ,1975
- 5-Fluorouracil in the Treatment of Gastrointestinal NeoplasiaNew England Journal of Medicine, 1973
- Control of gene expression in carbohydrate, pyrimidine and DNA metabolismAdvances in Enzyme Regulation, 1971
- A Less Toxic Fluorouracil Dosage ScheduleJAMA, 1964
- The physiologic disposition of 5‐fluorouracil and 5‐fluoro‐2′‐deoxyuridine in manClinical Pharmacology & Therapeutics, 1964